Clinical cancer nanomedicine
Top Cited Papers
- 6 March 2019
- journal article
- review article
- Published by Elsevier BV in Nano Today
- Vol. 25, 85-98
- https://doi.org/10.1016/j.nantod.2019.02.005
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute Physical Sciences-Oncology Network of the National Institutes of Health (U54CA210181)
- Office of the Assistant Secretary of Defense for Health Affairs, through the Breast Cancer Research Program (W81XWH-17-1-0389)
- Mayo Clinic
This publication has 199 references indexed in Scilit:
- The transferrin receptor and the targeted delivery of therapeutic agents against cancerBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- Recent advances in stealth coating of nanoparticle drug delivery systemsWIREs Nanomedicine and Nanobiotechnology, 2012
- Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examinationEuropean Journal of Cancer, 2011
- The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting AgentsCancer Treatment Reviews, 2011
- Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiformeJournal of Neuro-Oncology, 2010
- Gadolinium Chloride Augments Tumor-Specific Imaging of Targeted Quantum Dots In VivoACS Nano, 2010
- Frontiers in cancer nanomedicine: directing mass transport through biological barriersTrends in Biotechnology, 2010
- Top‐down particle fabrication: control of size and shape for diagnostic imaging and drug deliveryWIREs Nanomedicine and Nanobiotechnology, 2009
- Protease‐Triggered Unveiling of Bioactive NanoparticlesSmall, 2008
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3Nature, 2008